Key result
Severe functional tricuspid regurgitation was strongly associated with mortality in patients with pulmonary hypertension over a median 26-month follow-up, during which 29.2% of patients died.
Why the study?
The study aimed to evaluate the association between functional tricuspid regurgitation severity and mortality in patients with pulmonary hypertension in western China.
Cohort (n=136)
FTR severity may aid PH prognostication; hypothesis-generating and should not yet change practice.
Pulmonary hypertension (PH) is a hemodynamic and pathophysiologic state present in many cardiovascular, respiratory, and systemic diseases. PH is considered to have a higher risk of cardiovascular events and mortality. The most common type of functional tricuspid regurgitation (FTR) is associated with PH. The aim of this study was to evaluate the association between FTR severity and mortality in PH in western China. This is a retrospective analysis in PH patients and all patients underwent right-heart catheterization (RHC) for hemodynamic measurements. The FTR severity was determined according to the guidelines. Uni- and multivariate analyses were used to identify risk factors for mortality. From 2015 to 2021, 136 patients with PH with a median age of 50 years (interquartile range [IQR]: 35-64 years). During 26-month median follow-up (mean 27.7 ± 15.1 months), 40 (29.2%) patients died (mean after 21.7 ± 14.1 months). In the univariate Cox regression analysis, World Health Organization functional class (WHO FC) III/IV, elevated B-type natriuretic peptide, pulmonary vascular resistance (≥16.2 Wood units), pulmonary artery oxygen saturation, severe FTR and right ventricular diameter/left ventricular diameter (≥0.62) were significantly associated with mortality. In the multivariate Cox regression analysis, severe FTR, WHO FC III/IV, and right ventricular end-diastolic pressure (RVEDP) were risk factors for mortality. Severe FTR at baseline was strongly associated with mortality in both precapillary and postcapillary PH patients, independent of the other risk factors as RVEDP, HO FC III/IV, optimal pulmonary arterial hypertension targeted therapy.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2023) conducted a cohort in Pulmonary hypertension (n=136). Severe functional tricuspid regurgitation was evaluated on Mortality. Severe functional tricuspid regurgitation was strongly associated with mortality in patients with pulmonary hypertension over a median 26-month follow-up, during which 29.2% of patients died.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: